We are live on ! Find out more
Swiss National Bank

Swiss National Bank Portfolio holdings

AUM $174B
1-Year Est. Return 30.96%
 

The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.

This Fund
S&P 500
This Quarter Est. Return
+4%
1 Year Est. Return
+30.96%
3 Year Est. Return
+104.8%
5 Year Est. Return
+143.7%
10 Year Est. Return
+536.36%
AUM
$61.8B
AUM Growth
+$7.3B
Cap. Flow
+$3.47B
Cap. Flow %
5.61%
Top 10 Hldgs %
15.31%
Holding
2,670
New
59
Increased
1,417
Reduced
325
Closed
89

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$106M
2
NXPI icon
NXP Semiconductors
NXPI
+$93.6M
3
BABA icon
Alibaba
BABA
+$90M
4
XOM icon
ExxonMobil
XOM
+$83.7M
5
CHTR icon
Charter Communications
CHTR
+$82.8M

Sector Composition

Rank Sector Weight
1 Healthcare 15.13%
2 Technology 14.52%
3 Consumer Staples 10.68%
4 Consumer Discretionary 10.21%
5 Industrials 9.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IMMR icon
2526
Immersion
IMMR
$257M
$279K ﹤0.01%
38,000
BCRX icon
2527
BioCryst Pharmaceuticals
BCRX
$2.51B
$273K ﹤0.01%
96,300
BGFV
2528
DELISTED
Big 5 Sporting Goods
BGFV
$273K ﹤0.01%
29,500
ONIT
2529
Onity Group
ONIT
$326M
$270K ﹤0.01%
10,520
-1,060
-9% -$32.7K
ONDK
2530
DELISTED
On Deck Capital, Inc.
ONDK
$270K ﹤0.01%
52,400
-8,400
-14% -$50.3K
IBRX icon
2531
ImmunityBio
IBRX
$7.94B
$264K ﹤0.01%
42,450
+6,100
+17% +$47.4K
CMRX
2532
DELISTED
Chimerix, Inc.
CMRX
$259K ﹤0.01%
65,800
SSI
2533
DELISTED
Stage Stores Inc
SSI
$256K ﹤0.01%
52,500
ATEX icon
2534
Anterix
ATEX
$1.81B
$253K ﹤0.01%
11,850
+2,100
+22% +$66.1K
RPD icon
2535
Rapid7
RPD
$776M
$252K ﹤0.01%
20,000
KPTI icon
2536
Karyopharm Therapeutics
KPTI
$44.4M
$247K ﹤0.01%
2,457
+167
+7% +$21.7K
NGVC icon
2537
Vitamin Cottage Natural Grocers
NGVC
$605M
$247K ﹤0.01%
18,900
DLTH icon
2538
Duluth Holdings
DLTH
$151M
$245K ﹤0.01%
+10,000
New +$235K
CACB
2539
DELISTED
Cascade Bancorp
CACB
$245K ﹤0.01%
44,300
WEYS icon
2540
Weyco Group
WEYS
$441M
$244K ﹤0.01%
8,800
CONN
2541
DELISTED
Conn's Inc.
CONN
$244K ﹤0.01%
32,400
LCTX icon
2542
Lineage Cell Therapeutics
LCTX
$286M
$243K ﹤0.01%
106,512
+26,959
+34% +$66.1K
QADA
2543
DELISTED
QAD Inc.
QADA
$243K ﹤0.01%
12,600
EDIT icon
2544
Editas Medicine
EDIT
$432M
$242K ﹤0.01%
+9,900
New +$334K
CFMS
2545
DELISTED
Conformis, Inc. Common Stock
CFMS
$236K ﹤0.01%
1,344
JONE
2546
DELISTED
Jones Energy, Inc.
JONE
$236K ﹤0.01%
3,121
-402
-11% -$30.4K
NEWS
2547
DELISTED
NewStar Financial, Inc.
NEWS
$235K ﹤0.01%
27,900
BNK
2548
DELISTED
C1 FINL INC COM STK (FL)
BNK
$233K ﹤0.01%
+10,000
New +$237K
TPST icon
2549
Tempest Therapeutics
TPST
$16.6M
$232K ﹤0.01%
15
+3
+25% +$68.5K
CTMX icon
2550
CytomX Therapeutics
CTMX
$750M
$230K ﹤0.01%
+22,500
New +$257K

Similar funds

Swiss National Bank's Q2 2016 Portfolio in Review

As of Q2 2016, Swiss National Bank held 2,670 positions worth $61.8B, up 13% from $54.5B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Swiss National Bank deployed $3.47B of net new capital in Q2 2016, opening 59 new positions and adding to 1,417 existing holdings. Its largest new stake was Under Armour Class C: 522,612 shares worth $19M.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 15% a quarter earlier, followed by Technology and Consumer Staples.

On the sell side, the largest reduction was Kimberly-Clark, an estimated $19.6M trimmed.

  • Swiss National Bank's largest Q2 2016 buy was Under Armour Class C: 522,612 shares worth $19M.
  • Swiss National Bank added most to Apple in Q2 2016, an estimated $106M increase.
  • Swiss National Bank's biggest Q2 2016 reduction was Kimberly-Clark, cutting an estimated $19.6M.
  • Swiss National Bank fully exited Brookfield in Q2 2016, selling an estimated $162M.
  • Swiss National Bank's ten largest holdings make up 15% of its $61.8B portfolio in Q2 2016.
  • Swiss National Bank opened 59 new positions and closed 89 in Q2 2016.
  • Swiss National Bank's portfolio value rose 13% quarter-over-quarter to $61.8B.

Based on Swiss National Bank's 13F filing for Q2 2016, filed 3 Aug 2016.